SciELO - Scientific Electronic Library Online

 
vol.93 issue5ABC award finalists confirm Archives as a channel of diffusion of the Brazilian scientific productionDiet prescription in chronic heart failure: why don't we do it? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Arquivos Brasileiros de Cardiologia

Print version ISSN 0066-782X

Arq. Bras. Cardiol. vol.93 no.5 São Paulo Nov. 2009

http://dx.doi.org/10.1590/S0066-782X2009001100002 

EDITORIAL

 

Transesophageal echocardiography: how safe is it?

 

 

Márcia de Melo Barbosa

Ecoenter- Hospital Socor, Belo Horizonte, MG - Brazil

Mailing address

 

 


Key words: Echocardiography, transesophageal / complications; safety


 

 

Transesophageal echocardiography (TEE) is an essential diagnostic tool, broadly used in cardiology. It is considered a semi-invasive, but safe, procedure, although objective data on the events that occur during or after the procedure are scarce. The study by Cury et al1, about the safety of TEE, published in this issue of the Arquivos Brasileiros de Cardiologia (The Brazilian Archives of Cardiology), reports the experience of a single center regarding the complications of TEE in 137 patients. These were more related to sedation with Midazolan > 5 mg, presence of cardiomyopathy and presence of significant mitral regurgitation.

Pioneer studies have shown that the rate of severe events that occurred as TEE complications ranged from 0.18 to 0.5%2,3. However, most of the 10,419 patients included in the study by Daniel et al2 was awake, and thus, the possible complications of sedation were underestimated2. Even when the TEE is carried out in patients hemodynamically unstable, the test is quite safe, as demonstrated by Sohn et al., who did not observe any significant complications during TEE performed in 124 critically ill patients4.

Ideally, the hemodynamic parameters must be monitored during the TEE, as carried out by Cury et al1, who monitored the blood pressure and oxymetry. A previous study that monitored the blood pressure in 54 non-sedated patients, showed an increase in the blood pressure in 77% of the cases and a decrease in 22%. One patient developed an intermittent second-degree AV block, which, however, disappeared after the TEE. There was no arrhythmia onset or increase with the test5. The study by Cury et al1 did not show the presence of arrhythmias, either. The authors did not mention the occurrence of bleeding and trauma, although they are the most frequent complications in the literature. A study carried out in 10,000 patients showed a rate of hypopharynx, esophageal or gastric perforation of 0.03%. The authors concluded that dyspnea, coughing, odynophagia and hemoptysis symptoms after a TEE suggest the diagnosis of perforation and must be rapidly investigated6.

Although the study by Cury et al1 does not mention the use of anticoagulants, the literature suggests that the TEE is safe in patients using them. However, there has been a report of a case of esophageal hemorrhage in a patient that received thrombolytic therapy for the treatment of prosthesis thrombosis diagnosed by the TEE, suggesting that the thrombolytic therapy immediately after the TEE can be associated to a higher risk of bleeding2.

The risk of bacteremia with TEE is small7,8 and the Guidelines for Endocarditis Prophylaxis of the American Heart Association do not recommend antibiotic prophylaxis for endocarditis in patients submitted to TEE9. Very few deaths have been described in the literature2.

 

Intraoperative TEE

Although the study by Cury et al1did not include intraoperative TEE, studies that analyze the complications of intraoperative TEE are important because they reflect the consequences of the presence of the transesophageal probe for a longer period of time. A study with 155 academic institutions in the USA showed that 91% routinely perform intraoperative TEE10, showing its large scope. In a study of 7,200 patients submitted to intraoperative TEE, the morbidity and the mortality of the procedure were 0.2% and 0%, respectively. These data are comparable to the rates of endoscopy complications11.

The injury mechanism with the TEE transducer in cardiac surgery can be multifactorial: effects of local pressure, vascular failure, local thermal tissue injury impaired blood supply to the mucosa by cardiopulmonary bypass surgery, among others12.

Lennon et al12 analyzed the late gastrointestinal complications (24 hrs after the intraoperative TEE) and that can be the cause of a higher incidence of these complications in their study, as other authors did not analyze late complications of intraoperative TEE. Although it is a retrospective study, the authors emphasize the possibility of these late events and suggest that the post-TEE endoscopy is carried out with a low degree of suspicion12. The study by Cury et al1 did not assess the occurrence of late complications and, therefore, the rate of events related to TEE can be in fact underestimated.

In conclusion, TEE has currently an important impact in the diagnosis and management of several cardiac diseases. Although it is a semi-invasive test, previous and recent studies show a low rate of complications. That, however, does not mean that the contraindications should not be respected and that the risk-benefit should not be evaluated individually. The study by Cury et al1 has demonstrated the safety of this method in our country, even in sedated patients and in patients with systolic dysfunction.

 

 

References

1. Cury AF, Vieira MLC, Fischer CH, Rodrigues ACT, Cordovil A, Monaco C, et al. Segurança da ecocardiografia transesofágica em adultos: estudo em um hospital multidisciplinar. Arq Bras Cardiol. 2009. (In Press).         [ Links ]

2. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, et al. Safety of transesophageal echocardiography: a multicenter study of 10,419 examinations. Circulation. 1991; 83: 817-21.         [ Links ]

3. Khandheria BK, Oh J. Transesophageal echocardiography: State–of-the-art and future directions. Am J Cardiol. 1992; 69: 61H-75H.         [ Links ]

4. Sohn DW, Shin GJ, Oh JK, Tajik AJ, Click RL, Miller FA, et al. Role of transesophageal echocardiography in hemodynamically unstable patients. Mayo Clin Proc. 1995; 70: 925-31.         [ Links ]

5. Geigel A, Kasper W, Behroz A, Przewolka U, Meinertz T, Just H. Risk of transesophageal echocardiography in awake patients with cardiac disease. Am J Cardiol. 1988; 62: 337-9.         [ Links ]

6. Min JK, Spencer KT, Furlong KT, DeCara JM, Sugeng L, Ward RP, et al. Clinical features of complications from transesophageal echocardiography: a single center case series of 10,000 consecutive examinations. J Am Soc Echocardiogr. 2005; 18 (9): 925-9.         [ Links ]

7. Melendez LJ, Chan KL, Cheung PK, Sochowski RA, Wong S, Austin TW. Incidence of bacteremia in transesophageal echocardiography: a prospective study of 140 consecutive patients. J Am Coll Cardiol. 1991; 18 (7): 1650-4.         [ Links ]

8. Steckelberg JM, Khandheria BK, Anhalt JP, Ballard DJ, Seward JB, Click RL, et al. Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation. 1991; 84 (1): 177-80.         [ Links ]

9. Wilson W, Taubert KA, Gewitz M, Lockhart P, Baddour LM, Levinson M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007; 116: 1736-54.         [ Links ]

10. Poterack KA. Who uses transesophageal echocardiography in the operating room? Anesth Analg. 1995; 80: 454-8.         [ Links ]

11. Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK. The safety of intraoperative transesophageal echocardiography: a case series of 7200 cardiac surgical patients. Anesth Analg. 2001; 92: 1126-30.         [ Links ]

12. Lennon M, Gibbs NM, Weightman WM, Leber J, Ee HC, Yusoff IF. Transesophageal echocardiography-related gastrointestinal complications in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2005; 19: 141-5.         [ Links ]

 

 

Mailing address:
Márcia de Melo Barbosa
Al Conde do Rio Pardo, 288, Vila do Conde,
34.000-000, Nova Lima, MG - Brazil
E-mail: marciambarbosa@terra.com.br, mmbarbosa@cardiol.br

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License